Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DXCM

Dexcom Inc

Sep 06 • 04:00PM ET

68.61

Dollar change -0.44
Percentage change -0.64	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO VO QQQ SPY IVV VUG XLV VOT IWP

Scroll to Statements

Index	NDX, S&P 500	P/E	42.28	EPS (ttm)	1.62	Insider Own	1.41%	Shs Outstand	400.73M	Perf Week	-1.45%
Market Cap	27.49B	Forward P/E	33.96	EPS next Y	2.02	Insider Trans	-3.83%	Shs Float	395.07M	Perf Month	-1.02%
Income	666.90M	PEG	2.61	EPS next Q	0.44	Inst Own	94.65%	Short Float	1.91%	Perf Quarter	-40.49%
Sales	3.93B	P/S	6.99	EPS this Y	11.52%	Inst Trans	-0.34%	Short Ratio	1.43	Perf Half Y	-48.51%
Book/sh	6.08	P/B	11.29	EPS next Y	19.20%	ROA	9.79%	Short Interest	7.56M	Perf Year	-35.81%
Cash/sh	7.79	P/C	8.81	EPS next 5Y	16.20%	ROE	29.41%	52W Range	62.34 - 142.00	Perf YTD	-44.71%
Dividend Est.	-	P/FCF	41.31	EPS past 5Y	-	ROI	13.32%	52W High	-51.68%	Beta	1.18
Dividend TTM	-	Quick Ratio	2.48	Sales past 5Y	28.80%	Gross Margin	62.75%	52W Low	10.06%	ATR (14)	3.18
Dividend Ex-Date	-	Current Ratio	2.82	EPS Y/Y TTM	85.77%	Oper. Margin	17.32%	RSI (14)	36.12	Volatility	3.74% 3.50%
Employees	9600	Debt/Eq	1.07	Sales Y/Y TTM	23.05%	Profit Margin	16.95%	Recom	1.59	Target Price	96.18
Option/Short	Yes / Yes	LT Debt/Eq	1.06	EPS Q/Q	26.60%	Payout	0.00%	Rel Volume	0.67	Prev Close	69.05
Sales Surprise	-3.17%	EPS Surprise	11.34%	Sales Q/Q	15.26%	Earnings	Jul 25 AMC	Avg Volume	5.28M	Price	68.61
SMA20	-4.53%	SMA50	-22.48%	SMA200	-40.69%	Trades		Volume	3,532,581	Change	-0.64%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$535
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$575
Jan-07-22	Upgrade	Guggenheim	Neutral → Buy	$580
Oct-18-21	Downgrade	Guggenheim	Buy → Neutral
Jul-21-21	Resumed	Cowen	Outperform	$540 → $525
May-28-21	Upgrade	Wells Fargo	Underweight → Equal Weight	$380
May-25-21	Initiated	Barclays	Overweight	$500
Apr-15-21	Initiated	Atlantic Equities	Overweight	$438

Show Previous Ratings

Sep-06-24 07:33AM	DexCom (DXCM) Faces Investor Backlash After Disappointing Earnings Report - Hagens Berman (Newsfile)
Sep-05-24 02:59PM	DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth - Hagens Berman (GlobeNewswire)
09:00AM	Heres Why DexCom (DXCM) Fell in Q2 (Insider Monkey)
08:45AM	DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM (PR Newswire)
Sep-04-24 04:00AM	Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium (Business Wire)
05:12PM	Loading…
Sep-03-24 05:12PM	S&P 500 Gains and Losses Today: Index Plunges To Start September (Investopedia)
12:40PM	DexCom Is the Best Performing Stock in the Nasdaq 100 Tuesday (Barrons.com)
Sep-02-24 02:00PM	DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth - Hagens Berman (GlobeNewswire)
07:12AM	Is DexCom a Millionaire-Maker Stock? (Motley Fool)
Aug-30-24 02:01PM	DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth Hagens Berman (GlobeNewswire)
08:06AM	DexCom Stock Got Crushed After an Earnings Miss. A New Product Could Bail It Out. (Barrons.com)
Aug-28-24 08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
04:40AM	DexCom (DXCM) Accused of Misleading Investors - Hagens Berman (Newsfile)
Aug-26-24 04:25PM	Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back? (Investor's Business Daily)
03:36PM	DexCom (DXCM) Accused of Misleading Investors - Hagens Berman (GlobeNewswire)
02:47PM	Loading…
02:47PM	Jim Cramer Says One of the Most Dramatic Declines Of This Year Comes From DexCom Inc. (DXCM)' (Insider Monkey)
12:43PM	Dexcom prices first over-the-counter glucose monitor (MedTech Dive)
06:00AM	Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available (Business Wire)
Aug-23-24 03:24AM	DexCom (DXCM) Accused of Misleading Investors - Hagens Berman (Newsfile)
Aug-21-24 09:42PM	DexCom (DXCM) Accused of Misleading Investors - Hagens Berman (GlobeNewswire)
04:50PM	Viking Therapeutics could be a new winner in the GLP-1 space (Yahoo Finance Video)
06:30AM	Is It Time to Buy July's Worst-Performing S&P 500 Stocks? (Motley Fool)
Aug-20-24 05:25PM	S&P 500 Gains and Losses Today: Palo Alto Networks Surges After Earnings Beat (Investopedia) -6.23%
05:21PM	These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise (Investopedia)
12:11PM	Top Stock Movers Now: Boeing, Lowe's, Netflix, Eli Lilly, and More (Investopedia)
07:12AM	Should You Hold DexCom (DXCM)? (Insider Monkey)
Aug-19-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Iris Energy, and DexCom and Encourages Investors to Contact the Firm (GlobeNewswire)
Aug-18-24 10:45AM	2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200 (Motley Fool)
07:10AM	2 Growth Stocks to Buy at a Discount (Motley Fool)
Aug-16-24 09:09PM	What Makes DexCom, Inc. (DXCM) a Good Diabetes Stock to Buy According to Hedge Funds? (Insider Monkey)
05:00PM	Loading…
05:00PM	S&P 500 Gains and Losses Today: Amcor Slides After Packaging Firm's Sales Miss (Investopedia)
01:20PM	DexCom's (DXCM) G7 CGM Coverage Expanded for Quebec Residents (Zacks)
08:56AM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About Disruptive Sales Force Expansion, Shares Plummet - Hagens Berman (GlobeNewswire)
07:17AM	1 Growth Stock Down 43% to Buy Right Now (Motley Fool)
Aug-14-24 01:14PM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About "Disruptive" Sales Force Expansion, Shares Plummet - Hagens Berman (Newsfile)
08:00AM	RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Quebec Residents (Business Wire)
08:00AM	RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Qubec Residents (Business Wire)
Aug-12-24 09:53AM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About Disruptive Sales Force Expansion, Shares Plummet - Hagens Berman (GlobeNewswire)
Aug-11-24 07:37AM	The 'G' in ESG is gaining more shareholder love than the 'E' or 'S' (Yahoo Finance)
Aug-10-24 03:55PM	Quanta Services Inc. (PWR): Among the Top Stocks Recommended by Navellier & Associates? (Insider Monkey)
Aug-09-24 10:00AM	Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom (Benzinga)
Aug-08-24 12:21PM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About Disruptive Sales Force Expansion, Shares Plummet - Hagens Berman (GlobeNewswire)
10:00AM	Should You Buy DexCom Stock After Its Post-Earnings Sell-Off? (Motley Fool)
08:45AM	These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip? (Motley Fool)
Aug-07-24 08:30PM	Lightning Round: Stay away from Dexcom, says Jim Cramer (CNBC TV) -7.88%
04:57PM	Chips, Glorious Chips! (Motley Fool)
08:41AM	Is It Time to Buy July's Worst-Performing Nasdaq Stocks? (Motley Fool)
Aug-06-24 07:00AM	Down 40% in 1 Day, Is DexCom Stock Still a Buy? (Motley Fool)
Aug-05-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Nano Nuclear, Iris Energy, Ford, and DexCom and Encourages Investors to Contact the Firm (GlobeNewswire)
05:06PM	DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM (PR Newswire)
03:57PM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About Disruptive Sales Force Expansion, Shares Plummet - Hagens Berman (GlobeNewswire)
Aug-02-24 04:00PM	Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow' (Benzinga)
08:00AM	As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott (Investor's Business Daily)
07:18AM	Does DexCom (DXCM) Have a Long Runway For Growth? (Insider Monkey)
Aug-01-24 03:03PM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About Disruptive Sales Force Expansion, Shares Plummet - Hagens Berman (GlobeNewswire)
Jul-31-24 12:23PM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About "Disruptive" Sales Force Expansion, Shares Plummet - Hagens Berman (Newsfile)
Jul-30-24 05:48AM	DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame? (Motley Fool)
Jul-29-24 04:07PM	DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About Disruptive Sales Force Expansion, Shares Plummet - Hagens Berman (GlobeNewswire) +5.44%
09:00AM	Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada (Business Wire)
05:54AM	Is Beaten-Down Dexcom Stock a Buy on the Dip? (Motley Fool)
04:43AM	2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000 (Motley Fool)
Jul-27-24 09:30AM	2 Magnificent Growth Stocks to Buy Right Now (Motley Fool)
Jul-26-24 06:42PM	Analyst Report: DexCom, Inc. (Morningstar Research) -40.66% +5.44%
06:33PM	Dexcom stock plummeting is an 'opportunity to add to positions', says Wolfe Research's Mike Polark (CNBC TV)
05:12PM	S&P 500 Gains and Losses Today: 3M Stock Skyrockets After Beat-and-Raise Report (Investopedia)
04:17PM	Dexcom Stock Crashes 41% After Slashing Its Guidance On A 'Painfully Self-Inflicted' Quarter (Investor's Business Daily)
04:16PM	These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More (Barrons.com)
04:07PM	Are GLP-1 drugs creating headwinds for medical device makers? (Yahoo Finance Video)
03:17PM	Midday movers: NVIDIA, Meta, Microsoft up, diabetes stock slumps (TheStreet)
02:23PM	These Stocks Are Moving the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More (Barrons.com)
01:55PM	June PCE inflation print, auto earnings: Morning Brief (Yahoo Finance Video)
01:26PM	Stocks jump on cool inflation data, 3M pops on earnings: Yahoo Finance (Yahoo Finance Video)
01:14PM	Top Stock Movers Now: 3M, Charter Communications, Dexcom, and More (Investopedia)
12:27PM	Newell Brands, 3M rise; Saia, DexCom fall, Friday, 7/26/2024 (Associated Press Finance)
12:19PM	DexCom's (DXCM) Q2 Earnings Beat Estimates, Revenues Miss (Zacks)
12:03PM	DexCom Stock Plunges 40% After Earnings. GLP-1s Werent the Problem. (Barrons.com)
10:42AM	Why DexCom Stock Is Crashing Today (Motley Fool)
10:33AM	DexCom stock falls over 38% as revenue forecast declines (Medical Device Network)
10:25AM	These Stocks Are Moving the Most Today (Barrons.com)
10:19AM	DexCom stock plummets on revenue miss. Are GLP-1s a headwind? (Yahoo Finance Video)
09:37AM	Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge? (The Wall Street Journal)
07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
07:35AM	5 Things to Know Before the Stock Market Opens (Investopedia)
01:05AM	Decoding DexCom Inc (DXCM): A Strategic SWOT Insight (GuruFocus.com)
12:34AM	Dexcom shares crash nearly 40% as execution miss drives 2024 guidance cut (Investing.com)
Jul-25-24 11:00PM	DexCom (DXCM) Q2 2024 Earnings Call Transcript (Motley Fool)
09:47PM	Watch These Dexcom Price Levels as Stock Plunges After Guidance Slashed (Investopedia)
06:12PM	Dexcom shares plunge after it cuts annual revenue forecast (Reuters)
05:44PM	Dexcom Stock Plummets on Earnings Miss, Guidance Cut (Investopedia)
05:15PM	DexCom (DXCM) Q2 Earnings Surpass Estimates (Zacks)
05:09PM	Dexcom Stock Collapses 33% After Sales Miss Leads To $25 Million Guidance Cut (Investor's Business Daily)
04:14PM	DexCom: Q2 Earnings Snapshot (Associated Press Finance)
04:03PM	Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program (Business Wire)
Jul-23-24 07:31AM	CGM Sensor Demand Likely to Drive DexCom (DXCM) Q2 Earnings (Zacks)
12:06AM	Is DexCom (DXCM) Trading at a Discount Now? (Insider Monkey)
Jul-17-24 08:00AM	Head-And-Shoulders Pattern Spots Short-Sale Entries, But Beware Of Potential Headaches (Investor's Business Daily)
Jul-15-24 09:45AM	Here's Why DexCom (DXCM) is a Strong Growth Stock (Zacks)
Jul-14-24 10:00AM	2 Healthcare Stocks to Buy at a Discount (Motley Fool)
Jul-08-24 10:28AM	3 Breakthrough Medical Device Stocks to Invest In Now (InvestorPlace)
Jul-05-24 11:54AM	DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs (Zacks)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brown Michael Jon	EVP, Chief Legal Officer	Aug 30 '24	Sale	70.00	686	48,020	65,636	Sep 03 04:22 PM
MICHAEL BROWN	Officer	Aug 30 '24	Proposed Sale	70.00	686	48,020		Aug 30 04:32 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 31 '24	Sale	69.55	652	45,347	66,249	Aug 01 07:23 PM
MICHAEL BROWN	Officer	Jul 31 '24	Proposed Sale	69.55	652	45,347		Jul 31 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Jun 28 '24	Sale	114.29	659	75,317	66,901	Jun 28 05:34 PM
FOLETTA MARK G	Director	Jun 18 '24	Sale	116.79	3,306	386,122	56,398	Jun 20 04:50 PM
FOLETTA MARK G	Director	Jun 17 '24	Sale	117.26	2,694	315,907	59,704	Jun 20 04:50 PM
Heller Bridgette P	Director	Jun 14 '24	Sale	113.55	1,000	113,550	25,349	Jun 18 07:16 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jun 10 '24	Sale	115.05	745	85,713	84,948	Jun 11 06:39 PM
Stern Sadie	EVP Chief HR Officer	Jun 10 '24	Sale	115.05	427	49,127	75,877	Jun 11 06:39 PM
Leach Jacob Steven	EVP Chief Operating Officer	Jun 10 '24	Sale	115.05	745	85,713	265,577	Jun 11 06:38 PM
Brown Michael Jon	EVP Chief Legal Officer	May 31 '24	Sale	119.24	652	77,744	67,560	May 31 05:27 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	May 15 '24	Sale	126.58	2,423	306,703	40,075	May 16 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Apr 30 '24	Sale	126.25	629	79,411	68,212	May 02 05:07 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	Apr 15 '24	Sale	137.81	1,990	274,242	42,377	Apr 16 04:16 PM
SAYER KEVIN R	President CEO and Chairman	Apr 08 '24	Sale	138.30	49,633	6,864,136	283,893	Apr 10 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Mar 28 '24	Sale	140.04	2,624	367,472	68,682	Mar 29 07:30 PM
Stern Sadie	EVP Chief Human Resources	Mar 25 '24	Sale	140.00	4,137	579,180	76,304	Mar 26 04:46 PM
Dolan Matthew Vincent	EVP Strategy & Corp Dev	Mar 15 '24	Sale	130.21	4,203	547,259	44,367	Mar 19 04:55 PM
Sylvain Jereme M	EVP Chief Financial Officer	Mar 12 '24	Sale	134.41	11,661	1,567,363	85,534	Mar 14 05:40 PM
Stern Sadie	EVP Chief Human Resources	Mar 12 '24	Sale	133.61	20,321	2,715,006	80,441	Mar 14 05:40 PM
SAYER KEVIN R	President CEO and Chairman	Mar 12 '24	Sale	133.36	81,007	10,802,803	333,526	Mar 14 05:40 PM
Leach Jacob Steven	EVP Chief Operating Officer	Mar 12 '24	Sale	134.41	14,639	1,967,638	273,913	Mar 14 05:40 PM
Lawver Teri L	EVP Chief Commercial Officer	Mar 12 '24	Sale	134.41	4,764	640,333	66,641	Mar 14 05:39 PM
Dolan Matthew Vincent	EVP Strategy and Corporate	Mar 12 '24	Sale	134.41	6,710	901,896	48,570	Mar 14 05:39 PM
Brown Michael Jon	EVP Chief Legal Officer	Mar 12 '24	Sale	134.41	8,799	1,182,680	71,306	Mar 14 05:39 PM
Sylvain Jereme M	EVP Chief Financial Officer	Feb 20 '24	Sale	116.73	3,363	392,563	71,142	Feb 21 05:48 PM
Stern Sadie	EVP Chief Human Resources	Jan 16 '24	Sale	123.63	2,902	358,788	79,051	Jan 17 06:56 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jan 16 '24	Sale	123.63	2,734	338,018	74,505	Jan 17 06:54 PM
SAYER KEVIN R	President, CEO and Chairman	Jan 16 '24	Sale	123.63	37,325	4,614,669	362,841	Jan 17 06:49 PM
Leach Jacob Steven	EVP Chief Operating Officer	Jan 16 '24	Sale	123.63	3,978	491,819	262,499	Jan 17 06:49 PM
ALTMAN STEVEN R	Director	Jan 16 '24	Sale	122.86	1,568	192,652	53,132	Jan 17 06:47 PM
AUGUSTINOS NICHOLAS	Director	Dec 15 '23	Sale	123.02	3,976	489,128	34,040	Dec 18 04:32 PM
ALTMAN STEVEN R	Director	Dec 15 '23	Sale	122.77	2,000	245,548	54,700	Dec 18 04:31 PM
ALTMAN STEVEN R	Director	Dec 12 '23	Sale	120.00	3,000	360,004	56,700	Dec 13 04:18 PM
Stern Sadie	EVP Chief Human Resources Offi	Dec 11 '23	Sale	117.66	392	46,123	76,008	Dec 11 06:15 PM
Brown Michael Jon	EVP Chief Legal Officer	Dec 01 '23	Sale	114.56	3,612	413,774	58,394	Dec 04 06:10 PM
Naganathan Girish	EVP Chief Technology Officer	Nov 09 '23	Sale	93.27	2,725	254,161	47,725	Nov 27 07:34 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Nov 24 '23	Sale	110.80	411	45,539	124,775	Nov 27 04:00 PM
Stern Sadie	EVP Chief Human Resources Offi	Nov 22 '23	Sale	110.00	1,176	129,360	76,400	Nov 24 03:51 PM
ALTMAN STEVEN R	Director	Nov 15 '23	Sale	101.26	1,000	101,256	59,700	Nov 15 06:36 PM
Regan Barry J.	EVP Operations	Nov 08 '23	Sale	95.22	2,019	192,249	64,250	Nov 08 04:05 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Oct 23 '23	Sale	85.75	411	35,243	125,186	Oct 23 07:43 PM
ALTMAN STEVEN R	Director	Oct 16 '23	Sale	77.58	1,000	77,580	60,700	Oct 17 04:15 PM
Pacelli Steven Robert	EVP Managing Director Dexcom V	Sep 22 '23	Sale	88.40	411	36,332	125,597	Sep 22 06:30 PM
ALTMAN STEVEN R	Director	Sep 15 '23	Sale	101.50	1,000	101,495	61,700	Sep 19 04:43 PM
Heller Bridgette P	Director	Sep 12 '23	Sale	106.56	600	63,936	23,731	Sep 13 07:55 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your FINVIZ experience